None
NL
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $7.50 Consensus Price Target from Brokerages
['Defense World Staff']
Defense World
Get Sana Biotechnology alerts:Several equities analysts have commented on SANA shares.
Sana Biotechnology (NASDAQ:SANA – Get Free Report) last released its quarterly earnings data on Monday, August 11th.
As a group, equities research analysts expect that Sana Biotechnology will post -1.16 earnings per share for the current year.
Sana Biotechnology Company Profile(Get Free Report)Sana Biotechnology, Inc, a biotechnology company, focuses on utilizing engineered cells as medicines.
Read MoreReceive News & Ratings for Sana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.